Is Medco Healthy?

Tuesday, 1 Apr 2008 | 6:52 PM ET
MHS CEO Talks Growth
An outlook on competition, growth and generic drugs, with David Snow, Medco Health Solutions chairman & CEO and Mad Money host Jim Cramer.

MedcoHealth Solutions has dropped 11% since Cramer’s December call, as the potential for Unitedhealth to withdraw its business has analysts downgrading the stock left and right. But CEO David Snow sees things differently.

Medco’s coming off a “phenomenal” sales year, Snow said, garnering $5 billion in new-name business. The future holds profits, too, he continued. The CEO rattled off figures like the $90 billion worth of brand-name drugs coming off patent by 2015 and the 5% increase in guidance the company offered during its last conference call.

“Every year someone finds something to worry about, and we work our way through it,” Snow said. “We are going to do that again.”

Cramer agreed: “I think the downgrades were uncalled for,” he said, adding that Medco is a multiyear mover. “I like MHS.”

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.